Found: 225
Select item for more details and to access through your institution.
Letter to the Editor: Glycemic Index/Load Effect on Amyotrophic Lateral Sclerosis Progression: Potential Interaction with Riluzole.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 1, p. 208, doi. 10.1002/ana.26970
- By:
- Publication type:
- Article
Reply to Glycemic Index/Load Effect on ALS Progression: Potential Interaction with Riluzole.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 1, p. 208, doi. 10.1002/ana.26971
- By:
- Publication type:
- Article
Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta‐analysis study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 7, p. 1, doi. 10.1111/ene.16281
- By:
- Publication type:
- Article
Riluzole for Cervical Myelopathy.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2415643, doi. 10.1001/jamanetworkopen.2024.15643
- By:
- Publication type:
- Article
Causal relationship between PCSK9 inhibitor and common neurodegenerative diseases: A drug target Mendelian randomization study.
- Published in:
- Brain & Behavior, 2024, v. 14, n. 6, p. 1, doi. 10.1002/brb3.3543
- By:
- Publication type:
- Article
Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 6, p. 2053, doi. 10.1093/brain/awae078
- By:
- Publication type:
- Article
Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1380655
- By:
- Publication type:
- Article
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00413-0
- By:
- Publication type:
- Article
SPTLC2 variants are associated with early‐onset ALS and FTD due to aberrant sphingolipid synthesis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 4, p. 946, doi. 10.1002/acn3.52013
- By:
- Publication type:
- Article
Neuroprotective effects of riluzole in Alzheimer's disease: A comprehensive review.
- Published in:
- Fundamental & Clinical Pharmacology, 2024, v. 38, n. 2, p. 225, doi. 10.1111/fcp.12955
- By:
- Publication type:
- Article
Electrochemical detection of the neurotransmitter glutamate and the effect of the psychotropic drug riluzole on its oxidation response.
- Published in:
- Analytical & Bioanalytical Chemistry, 2024, v. 416, n. 7, p. 1707, doi. 10.1007/s00216-024-05175-2
- By:
- Publication type:
- Article
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS.
- Published in:
- Frontiers in Neuroscience, 2024, p. 1, doi. 10.3389/fnins.2024.1348157
- By:
- Publication type:
- Article
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03293-3
- By:
- Publication type:
- Article
Accelerating drug development for amyotrophic lateral sclerosis: construction and application of a disease course model using historical placebo group data.
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03057-5
- By:
- Publication type:
- Article
Edaravone: A Novel Possible Drug for Cancer Treatment?
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1633, doi. 10.3390/ijms25031633
- By:
- Publication type:
- Article
Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1751, doi. 10.3390/ijms25031751
- By:
- Publication type:
- Article
Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1871, doi. 10.3390/ijms25031871
- By:
- Publication type:
- Article
A Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular Carcinoma.
- Published in:
- Journal of the Endocrine Society, 2024, v. 8, n. 2, p. 1, doi. 10.1210/jendso/bvad171
- By:
- Publication type:
- Article
Analysis of damage-associated molecular patterns in amyotrophic lateral sclerosis based on ScRNA-seq and bulk RNA-seq data.
- Published in:
- Frontiers in Neuroscience, 2023, p. 1, doi. 10.3389/fnins.2023.1259742
- By:
- Publication type:
- Article
Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 11, p. 1985, doi. 10.1002/acn3.51885
- By:
- Publication type:
- Article
T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1202834
- By:
- Publication type:
- Article
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 6, p. 2260, doi. 10.1002/med.21974
- By:
- Publication type:
- Article
N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 11, p. 2638, doi. 10.3390/pharmaceutics15112638
- By:
- Publication type:
- Article
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15340, doi. 10.3390/ijms242015340
- By:
- Publication type:
- Article
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00380-y
- By:
- Publication type:
- Article
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 10, p. 3068, doi. 10.1111/ene.15954
- By:
- Publication type:
- Article
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 10, p. 1, doi. 10.1210/jendso/bvad117
- By:
- Publication type:
- Article
The Aqueous Lyophilisate of Alchemilla Kiwuensis Engl. (Rosaceae) Displays Antiepileptogenic and Antiepileptic Effects on PTZ-induced Kindling in rats: Evidence of Modulation of Glutamatergic and GABAergic Pathways Coupled to Antioxidant Properties.
- Published in:
- Neurochemical Research, 2023, v. 48, n. 10, p. 3228, doi. 10.1007/s11064-023-03982-0
- By:
- Publication type:
- Article
Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02876-2
- By:
- Publication type:
- Article
Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 320, doi. 10.1002/npr2.12364
- By:
- Publication type:
- Article
Development of a robust UPLC-MS/MS method for the quantification of riluzole in human plasma and its application in pharmacokinetics.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1227354
- By:
- Publication type:
- Article
Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0277718
- By:
- Publication type:
- Article
Low T-cell reactivity to TDP-43 peptides in ALS.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1193507
- By:
- Publication type:
- Article
Electrochemical Determination of Epinephrine in Pharmaceutical Preparation Using Laponite Clay-Modified Graphene Inkjet-Printed Electrode.
- Published in:
- Molecules, 2023, v. 28, n. 14, p. 5487, doi. 10.3390/molecules28145487
- By:
- Publication type:
- Article
Author Correction: Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Abductor Pollicis Brevis/Abductor Digiti Minimi Compound Muscle Action Potential Ratio as a Diagnostic Marker for Amyotrophic Lateral Sclerosis.
- Published in:
- Caspian Journal of Neurological Sciences, 2023, v. 9, n. 3, p. 162, doi. 10.32598/CJNS.9.34.387.1
- By:
- Publication type:
- Article
Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein.
- Published in:
- European Journal of Translational Myology, 2023, v. 33, n. 3, p. 1, doi. 10.4081/ejtm.2023.11555
- By:
- Publication type:
- Article
Neurodegenerative Multioethiology Lou Gehrig's Disease - Genetic Mutations, Pharmacological Mechanisms and Applications of Rilusole.
- Published in:
- International Journal of Pharmaceutical Research & Allied Sciences, 2023, v. 12, n. 3, p. 61, doi. 10.51847/w9fRJSNXjp
- By:
- Publication type:
- Article
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 2006, doi. 10.3390/pharmaceutics15072006
- By:
- Publication type:
- Article
QUANTIFICATION OF HAZARDOUS HIGH BOILING SOLVENTS IMPURITIES IN ANTI-DIABETIC DRUG LINAGLIPTIN BY NOVEL GC-ALS METHOD DEVELOPMENT AND VALIDATION.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1089, doi. 10.31788/RJC.2023.1638331
- By:
- Publication type:
- Article
Inhibition of the MEK/ERK pathway suppresses immune overactivation and mitigates TDP-43 toxicity in a Drosophila model of ALS.
- Published in:
- Immunity & Ageing, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12979-023-00354-8
- By:
- Publication type:
- Article
Riluzole, a Derivative of Benzothiazole as a Potential Anti-Amoebic Agent against Entamoeba histolytica.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 6, p. 896, doi. 10.3390/ph16060896
- By:
- Publication type:
- Article
Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0285011
- By:
- Publication type:
- Article
Analysis of SOD1 variants in Chinese patients with familial amyotrophic lateral sclerosis.
- Published in:
- QJM: An International Journal of Medicine, 2023, v. 116, n. 5, p. 365, doi. 10.1093/qjmed/hcad010
- By:
- Publication type:
- Article
c-Jun N-Terminal Kinase Promotes Stress Granule Assembly and Neurodegeneration in C9orf72-Mediated ALS and FTD.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 17, p. 3186, doi. 10.1523/JNEUROSCI.1799-22.2023
- By:
- Publication type:
- Article
Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 3, p. e17, doi. 10.1093/brain/awac467
- By:
- Publication type:
- Article
Cure of Alzheimer's Dementia Requires Addressing All of the Affected Brain Cell Types.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2049, doi. 10.3390/jcm12052049
- By:
- Publication type:
- Article
Supramolecular Organization in Salts of Riluzole with Dihydroxybenzoic Acids—The Key Role of the Mutual Arrangement of OH Groups.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 878, doi. 10.3390/pharmaceutics15030878
- By:
- Publication type:
- Article
The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 3, p. 416, doi. 10.3390/diagnostics13030416
- By:
- Publication type:
- Article